Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY

R. Hughes* (Corresponding Author), R. Del Olmo, B. Make, D. Price, A. Agustí, E. Rapsomaniki, H. Müllerová, J. Vestbo

*Corresponding author for this work

Research output: Contribution to conferenceAbstract

Abstract

Background: NOVELTY (NCT02760329) is a global, prospective, observational study of patients with a physician-assigned diagnosis of asthma and/or COPD. Pre- and post-bronchodilator (BD) spirometry was performed at baseline. Objective: To compare spirometric markers of airflow obstruction and reversibility across the spectrum of obstructive lung disease.
Original languageEnglish
Publication statusAccepted/In press - 27 Jul 2020
Event30th ERS International Congress - Virtual Event
Duration: 7 Sep 20209 Sep 2020

Conference

Conference30th ERS International Congress
Period7/09/209/09/20

Fingerprint Dive into the research topics of 'Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY'. Together they form a unique fingerprint.

  • Cite this

    Hughes, R., Del Olmo, R., Make, B., Price, D., Agustí, A., Rapsomaniki, E., Müllerová, H., & Vestbo, J. (Accepted/In press). Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY. Abstract from 30th ERS International Congress, .